InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Adaptive Biotechnologies Corp

ADPT Clue Score46
United States Fiscal year ends December CIK 0001478320 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Katey Einterz Owen
26 Aug 2026
Director
Sell
9,615
$26.00
$249.99K
Kyle Piskel
18 May 2026
Chief Financial Officer
Sell
3,115
$13.04
$40.62K
Chad M Robins
11 Mar 2026
CEO and Chairman
Sell
329,600
$13.17
$4.34M
Chad M Robins
11 Mar 2026
CEO and Chairman
Sell
140,567
$13.17
$1.85M
Harlan S Robins
11 Mar 2026
Chief Scientific Officer
Sell
329,600
$13.17
$4.34M
Harlan S Robins
11 Mar 2026
Chief Scientific Officer
Sell
140,666
$13.17
$1.85M
Kyle Piskel
11 Mar 2026
Chief Financial Officer
Sell
18,672
$13.17
$245.91K
Sharon Benzeno
11 Mar 2026
Chief Commercial Ofc Imm Med
Sell
63,103
$13.17
$831.07K
Susan Bobulsky
11 Mar 2026
Chief Commercial Officer, MRD
Sell
41,338
$13.17
$544.42K
Michelle Renee Griffin
11 Mar 2026
Director
Sell
15,394
$13.91
$214.13K
Francis Lo
5 Mar 2026
Chief People Officer
Sell
38,074
$15.09
$574.54K
Robert Hershberg
10 Dec 2025
Director
Sell
22,968
$16.00
$367.49K
Kyle Piskel
17 Nov 2025
Chief Financial Officer
Sell
238
$14.05
$3.34K
Show all 172 transactions →

What was left out

Form 4 filings counted 91
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 36
Sales straight out of an exercise 123
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 5,328,696
History held since 2 Jul 2019